These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 33857816)

  • 1. HSV-1-encoded ICP0 degrades the host deubiquitinase BRCC36 to antagonize interferon antiviral response.
    Zhang L; Huang F; Liu J; Xu Y; Miao Y; Yuan Y; Chen X; Zhang HG; Wang J; Zheng H; Zuo Y
    Mol Immunol; 2021 Jul; 135():28-35. PubMed ID: 33857816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Molecular Mechanism of Herpes Simplex Virus 1 UL31 in Antagonizing the Activity of IFN-β.
    Gong L; Ou X; Hu L; Zhong J; Li J; Deng S; Li B; Pan L; Wang L; Hong X; Luo W; Zeng Q; Zan J; Peng T; Cai M; Li M
    Microbiol Spectr; 2022 Feb; 10(1):e0188321. PubMed ID: 35196784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes Simplex Virus 1 UL36USP Antagonizes Type I Interferon-Mediated Antiviral Innate Immunity.
    Yuan H; You J; You H; Zheng C
    J Virol; 2018 Oct; 92(19):. PubMed ID: 29997210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes Simplex Virus 1 Tegument Protein UL41 Counteracts IFIT3 Antiviral Innate Immunity.
    Jiang Z; Su C; Zheng C
    J Virol; 2016 Dec; 90(24):11056-11061. PubMed ID: 27681138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immediate-early protein, ICP0, is essential for the resistance of herpes simplex virus to interferon-alpha/beta.
    Härle P; Sainz B; Carr DJ; Halford WP
    Virology; 2002 Feb; 293(2):295-304. PubMed ID: 11886249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of Small-Molecule Inhibitors Targeting the E3 Ubiquitin Ligase Activity of the Herpes Simplex Virus 1 ICP0 Protein Using an
    Deschamps T; Waisner H; Dogrammatzis C; Roy A; Chacko S; Perera C; Prisinzano TE; Kalamvoki M
    J Virol; 2019 Jul; 93(13):. PubMed ID: 30996104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of the Antiviral Factor Interferon Gamma-Inducible Protein 16 (IFI16) Mediate Immune Signaling and Herpes Simplex Virus-1 Immunosuppression.
    Diner BA; Lum KK; Javitt A; Cristea IM
    Mol Cell Proteomics; 2015 Sep; 14(9):2341-56. PubMed ID: 25693804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative Contributions of Herpes Simplex Virus 1 ICP0 and vhs to Loss of Cellular IFI16 Vary in Different Human Cell Types.
    Orzalli MH; Broekema NM; Knipe DM
    J Virol; 2016 Sep; 90(18):8351-9. PubMed ID: 27412599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PML plays both inimical and beneficial roles in HSV-1 replication.
    Xu P; Mallon S; Roizman B
    Proc Natl Acad Sci U S A; 2016 May; 113(21):E3022-8. PubMed ID: 27162364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes simplex virus type 1 regulatory protein ICP0 aids infection in cells with a preinduced interferon response but does not impede interferon-induced gene induction.
    Everett RD; Orr A
    J Virol; 2009 May; 83(10):4978-83. PubMed ID: 19264774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes simplex virus 1 targets IRF7 via ICP0 to limit type I IFN induction.
    Shahnazaryan D; Khalil R; Wynne C; Jefferies CA; Ní Gabhann-Dromgoole J; Murphy CC
    Sci Rep; 2020 Dec; 10(1):22216. PubMed ID: 33335135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ICP0 Protein of Herpes Simplex Virus 1 (HSV-1) Downregulates Major Autophagy Adaptor Proteins Sequestosome 1 and Optineurin during the Early Stages of HSV-1 Infection.
    Waisner H; Kalamvoki M
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31375597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of herpes simplex virus ICP0 inhibits the induction of interferon-stimulated genes by viral infection.
    Eidson KM; Hobbs WE; Manning BJ; Carlson P; DeLuca NA
    J Virol; 2002 Mar; 76(5):2180-91. PubMed ID: 11836395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Human Cytomegalovirus IE1 Leads to Accumulation of Mono-SUMOylated PML That Is Protected from Degradation by Herpes Simplex Virus 1 ICP0.
    Hou W; Cruz-Cosme R; Wen F; Ahn JH; Reeves I; Luo MH; Tang Q
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30258013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCC36 functions noncatalytically to promote antiviral response by maintaining STAT1 protein stability.
    Cheng Q; Feng Q; Xu Y; Zuo Y; Liu J; Yuan Y; Miao Y; Liu Y; Lei L; Guo T; Zhang L; Wu D; Zheng H
    Eur J Immunol; 2021 Feb; 51(2):296-310. PubMed ID: 32673428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type I interferon production during herpes simplex virus infection is controlled by cell-type-specific viral recognition through Toll-like receptor 9, the mitochondrial antiviral signaling protein pathway, and novel recognition systems.
    Rasmussen SB; Sørensen LN; Malmgaard L; Ank N; Baines JD; Chen ZJ; Paludan SR
    J Virol; 2007 Dec; 81(24):13315-24. PubMed ID: 17913820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADP-ribosyltransferase PARP11 modulates the interferon antiviral response by mono-ADP-ribosylating the ubiquitin E3 ligase β-TrCP.
    Guo T; Zuo Y; Qian L; Liu J; Yuan Y; Xu K; Miao Y; Feng Q; Chen X; Jin L; Zhang L; Dong C; Xiong S; Zheng H
    Nat Microbiol; 2019 Nov; 4(11):1872-1884. PubMed ID: 30988430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recruitment of activated IRF-3 and CBP/p300 to herpes simplex virus ICP0 nuclear foci: Potential role in blocking IFN-beta induction.
    Melroe GT; Silva L; Schaffer PA; Knipe DM
    Virology; 2007 Apr; 360(2):305-21. PubMed ID: 17126870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin-specific protease 9X in host cells interacts with herpes simplex virus 1 ICP0.
    Sato Y; Kato A; Arii J; Koyanagi N; Kozuka-Hata H; Oyama M; Kawaguchi Y
    J Vet Med Sci; 2016 Mar; 78(3):405-10. PubMed ID: 26596467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ICP0 prevents RNase L-independent rRNA cleavage in herpes simplex virus type 1-infected cells.
    Sobol PT; Mossman KL
    J Virol; 2006 Jan; 80(1):218-25. PubMed ID: 16352546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.